News AbbVie Inc. BOERSE MUENCHEN

Equities

Real-time BOERSE MUENCHEN Other stock markets 03:44:04 2024-07-15 pm EDT			5-day change	1st Jan Change
154.1 ^EUR	-1.65%		+0.01%	+10.28%

Jul. 12	AbbVie Submits FDA, EMA Applications for Upadacitinib to Treat Giant Cell Arteritis	MT
Jul. 12	AbbVie Seeks U.S., Europe OK of Rinvoq in Giant Cell Arteritis	DJ

AbbVie Submits Regulatory Applications to FDA and EMA for Upadacitinib in Giant Cell Arteritis	Jul. 15	AQ
Ex-dividend day	Jul. 14	FA
AbbVie Submits FDA, EMA Applications for Upadacitinib to Treat Giant Cell Arteritis	Jul. 12	MT
AbbVie Seeks U.S., Europe OK of Rinvoq in Giant Cell Arteritis	Jul. 12	DJ
AbbVie Submits Regulatory Applications to FDA and EMA for Upadacitinib (RINVOQ®) in Giant Cell Arteritis	Jul. 12	PR
AbbVie Announces Appointment of Roopal Thakkar, M.D. as Executive Vice President, Research and Development and Chief Scientific Officer	Jul. 11	AQ
Morgan Stanley Adjusts Price Target on AbbVie to $196 From $191	Jul. 11	MT
Redburn Atlantic Adjusts Price Target on AbbVie to $203 From $207	Jul. 10	MT
AbbVie Announces Appointment of Roopal Thakkar, M.D. as Executive Vice President, Research & Development and Chief Scientific Officer	Jul. 10	PR
Abbvie Announces Appointment of Roopal Thakkar as Executive Vice President, Research & Development and Chief Scientific Officer	Jul. 10	CI
Mixed feelings	Jul. 09
That's not so bad, is it?	Jul. 08
Sector Update: Health Care Stocks Steady Premarket Friday	Jul. 05	MT
AbbVie Flags Hit to Q2 Adjusted Earnings from R&D Expenses, Revises 2024 Outlook	Jul. 05	MT
AbbVie cuts 2024 profit forecast	Jul. 03	RE
AbbVie : Results of Operations and Financial Condition Form 8 K	Jul. 03	PU
AbbVie to Host Second-Quarter 2024 Earnings Conference Call	Jul. 02	PR
Merus Names New Chief Medical Officer	Jul. 01	MT
AbbVie: new CEO takes up post	Jul. 01	CF
AbbVie Says Robert Michael Assumes CEO Role	Jul. 01	MT

No results for this search